ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Two Different Influenza Vaccines in Healthy Children Aged 6 to <60 Months

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00649883
Recruitment Status : Completed
First Posted : April 1, 2008
Last Update Posted : April 7, 2017
Sponsor:
Collaborator:
Novartis Vaccines
Information provided by (Responsible Party):
Novartis

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2008
  Actual Study Completion Date : October 2008